Abbott Recalls Trifecta Heart Valves From U.S. Market Amid Concerns About Early Deterioration Problems
Abbott is pulling its Trifecta Heart Valves from the market due to the risk of early deterioration and failure, which has been linked to nearly 200 deaths.